Compare Suven Life Sciences with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE SCIENCES vs PFIZER - Comparison Results

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE SCIENCES PFIZER SUVEN LIFE SCIENCES/
PFIZER
 
P/E (TTM) x -82.3 42.6 - View Chart
P/BV x 1.3 7.1 18.3% View Chart
Dividend Yield % 1.8 0.5 368.2%  

Financials

 SUVEN LIFE SCIENCES   PFIZER
EQUITY SHARE DATA
    SUVEN LIFE SCIENCES
Mar-19
PFIZER
Mar-19
SUVEN LIFE SCIENCES/
PFIZER
5-Yr Chart
Click to enlarge
High Rs3383,840 8.8%   
Low Rs1692,080 8.1%   
Sales per share (Unadj.) Rs52.1455.0 11.5%  
Earnings per share (Unadj.) Rs6.893.8 7.3%  
Cash flow per share (Unadj.) Rs8.6109.4 7.8%  
Dividends per share (Unadj.) Rs1.5022.50 6.7%  
Dividend yield (eoy) %0.60.8 77.8%  
Book value per share (Unadj.) Rs65.3658.2 9.9%  
Shares outstanding (eoy) m127.2845.75 278.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.96.5 74.8%   
Avg P/E ratio x37.131.6 117.6%  
P/CF ratio (eoy) x29.627.1 109.3%  
Price / Book Value ratio x3.94.5 86.4%  
Dividend payout %22.024.0 91.5%   
Avg Mkt Cap Rs m32,272135,420 23.8%   
No. of employees `0001.12.6 41.1%   
Total wages/salary Rs m6613,238 20.4%   
Avg. sales/employee Rs Th6,132.27,911.4 77.5%   
Avg. wages/employee Rs Th611.11,230.9 49.6%   
Avg. net profit/employee Rs Th803.51,630.7 49.3%   
INCOME DATA
Net Sales Rs m6,63520,815 31.9%  
Other income Rs m2421,674 14.5%   
Total revenues Rs m6,87722,489 30.6%   
Gross profit Rs m1,6045,712 28.1%  
Depreciation Rs m221714 31.0%   
Interest Rs m3873 51.7%   
Profit before tax Rs m1,5876,599 24.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7182,309 31.1%   
Profit after tax Rs m8694,291 20.3%  
Gross profit margin %24.227.4 88.1%  
Effective tax rate %45.235.0 129.3%   
Net profit margin %13.120.6 63.6%  
BALANCE SHEET DATA
Current assets Rs m6,23227,167 22.9%   
Current liabilities Rs m1,4908,917 16.7%   
Net working cap to sales %71.587.7 81.5%  
Current ratio x4.23.0 137.3%  
Inventory Days Days8668 127.5%  
Debtors Days Days8330 274.4%  
Net fixed assets Rs m4,0438,862 45.6%   
Share capital Rs m127458 27.8%   
"Free" reserves Rs m8,18329,656 27.6%   
Net worth Rs m8,31030,113 27.6%   
Long term debt Rs m1825 71.2%   
Total assets Rs m10,38939,400 26.4%  
Interest coverage x43.191.5 47.1%   
Debt to equity ratio x00 258.0%  
Sales to assets ratio x0.60.5 120.9%   
Return on assets %8.711.1 78.8%  
Return on equity %10.514.2 73.4%  
Return on capital %19.522.1 88.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,622428 1,312.6%   
Fx outflow Rs m1,799786 228.8%   
Net fx Rs m3,822-358 -1,067.4%   
CASH FLOW
From Operations Rs m356978 36.3%  
From Investments Rs m-279351 -79.3%  
From Financial Activity Rs m-225-1,099 20.5%  
Net Cashflow Rs m-148231 -64.2%  

Share Holding

Indian Promoters % 63.4 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 0.0 7.5 -  
FIIs % 0.0 4.9 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 23.7 154.0%  
Shareholders   37,287 85,207 43.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE SCIENCES With:   ASTRAZENECA PHARMA  DR. DATSONS LABS  TTK HEALTHCARE  JUBILANT PHARMOVA   BIOCON   

Compare SUVEN LIFE SCIENCES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 447 Points Higher; Automobile & IT Stocks Rally(Closing)

Indian share markets witnessed buying interest during closing hours and ended today's volatile session higher.

Related Views on News

PFIZER Announces Quarterly Results (3QFY21); Net Profit Up 1.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, PFIZER has posted a net profit of Rs 1 bn (up 1.6% YoY). Sales on the other hand came in at Rs 6 bn (up 10.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (2QFY21); Net Profit Down 14.8% (Quarterly Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

For the quarter ended September 2020, PFIZER has posted a net profit of Rs 1 bn (down 14.8% YoY). Sales on the other hand came in at Rs 6 bn (up 5.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY21); Net Profit Up 10.3% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, PFIZER has posted a net profit of Rs 1 bn (up 10.3% YoY). Sales on the other hand came in at Rs 5 bn (down 5.4% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (3QFY20); Net Profit Up 5.4% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, PFIZER has posted a net profit of Rs 1 bn (up 5.4% YoY). Sales on the other hand came in at Rs 5 bn (up 4.7% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SCIENCES SHARE PRICE


Mar 2, 2021 (Close)

TRACK SUVEN LIFE SCIENCES

  • Track your investment in SUVEN LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFE SCIENCES

SUVEN LIFE SCIENCES 5-YR ANALYSIS

COMPARE SUVEN LIFE SCIENCES WITH

MARKET STATS